J. Kaburaki et al., CLINICAL-SIGNIFICANCE OF ANTI-ANNEXIN-V ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, American journal of hematology, 54(3), 1997, pp. 209-213
Annexin V has a calcium-dependent binding affinity for anionic phospho
lipids and activated platelets, and prevents prothrombinase activity.
We investigated the clinical significance of IgG anti-annexin V antibo
dies in patients with SLE. The study population consisted of 140 patie
nts with SLE. Sera were examined for IgG anti-annexin V antibodies by
ELISA. IgG anti-annexin V antibodies were detected in 27 of 140 patien
ts (19%). Significantly higher incidences of arterial or venous thromb
osis, intrauterine fetal loss, and prolonged activated partial thrombo
plastin time were found in patients with anti-annexin V antibodies tha
n in those without anti-annexin V antibodies. Three patients with thro
mbosis were found not to have anticardiolipin antibodies, but to show
sustained serological reactions for anti-annexin V antibodies, irrespe
ctive of prednisolone administration. These results indicated the clin
ical characteristics of SLE patients with anti-annexin V antibodies, a
nd that these antibodies may be associated with the pathogenesis of th
rombotic events. (C) Wiley-Liss, Inc.